Looking to publish in Current Drug Delivery? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowCurrent Drug Delivery is a journal with ISSN 1567-2018 and online ISSN 1875-5704. It has an Impact Factor of 3, is indexed in Scopus, SCI Expanded, and MEDLINE/PubMed, and publishes volume 23 in 2026.
Looking to publish in Current Drug Delivery? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Current Drug Delivery accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Mini-Reviews
Research Articles
Systematic Reviews
Randomized Drug Clinical Trial Studies
Short Communications
Case Reports
Recent Publications
Investigating FadD32 as a Target for 7-Substituted Coumarin Derivatives and Other Potential Antimycobacterial Agents
Sean Shamido, Jacques Joubert, Samantha Sampson, Afeez I. Kareem, Su-Mari du Plessis, Erika Kapp
Metal-Organic Frameworks: A Smart Platform for Targeted Drug Delivery in Cancer Therapy
Sandip Sonwane, Samiksha Khobragade, Rahul Ingle
Innovative Drug Delivery Strategies for Enhanced Treatment of Antimicrobial Resistance
Pranay Wal, Ankita Wal, Ajay Kumar, Hanish Singh Jayasingh Chellammal, Pratap Kumar Patra, Manish R. Bhise, Dileep Kumar, Sanjana Gupta, Amin Gasmi
Research Progress on Alzheimer's Disease with Classical Traditional Chinese Medicine Formulas
Jiarui Zhao, Geng Tian, Ying Qu, Yu Liu, Wenjie Wu, Lina Dai, Guowei Zhang, Fengmao An
Smart Stimuli-responsive Nanocarriers in Nanotechnology-based Cancer Diagnosis and Treatment
Soham Joshi, Ganesh Muleva, Laxmikant Borse, Kuldeep Vinchurkar, Sudarshan Singh
Frequently asked questions
How long does it take to publish?
Quick Track allows online publication within 2 weeks of receipt of final approved galley proofs. Total publication time from first receipt to online publication is 10 weeks, subject to acceptance and author revisions within one week. Revised manuscripts are usually requested within 15 days, and revision time may vary from one to four weeks.
Reformat to Current Drug Delivery using Livewrite PremiumIs a cover letter required?
A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Reformat to Current Drug Delivery using Livewrite PremiumWhat are the publication costs?
Publication charges for research and review articles are US $790 with limited-time OA for 6 months or US $1190 with limited-time OA for 12 months. Optional Gold Open Access is US $3695 per article for general submissions and US $1900 for thematic issues. Optional Quick Track publication is US $4845 per article.
Reformat to Current Drug Delivery using Livewrite Premium